CD
Benzodiazepine Abuse
search
Benzodiazepine Abuse
, Benzodiazepine Use Disorder, Benzodiazepine Dependence
See Also
Benzodiazepine
Benzodiazepine Withdrawal
Benzodiazepine Intoxication
Substance Use Disorder
Substance Abuse Evaluation
Epidemiology
Benzodiazepine
misuse in up to 17% of those in the U.S. taking
Benzodiazepine
s
Obtained from family or friends in 70% of misuse cases
Peak Age of
Benzodiazepine
misuse: 18 to 25 years old
Benzodiazepine
s are among the most prescribed controlled substances in the United State
Prescribed at >30 million office visits 2014-2016
Santo (2020) Natl Health Stat Report (137): 1-16 [PubMed]
Background
Benzodiazepine
s have rapid and effective anxiolysis and sedation of
Benzodiazepine
s
May be indicated for short-term use (<1 month) in refractory, severe anxiety and
Insomnia
However,
Benzodiazepine
s have little evidence of longterm, chronic use benefit
Wright (2022) J Fam Pract 71(3): 103-7 [PubMed]
Continued
Benzodiazepine
use significantly increases patient risk
See
Benzodiazepine
High risk of tolerance, dependence and misuse (see below)
Significant adverse effects, especially in over age 65 years (e.g. sedation, confusion, depression)
Falls,
Fracture
s and
Motor Vehicle Accident
s risk significantly increases on
Benzodiazepine
s
Risk of
Benzodiazepine Overdose
death when combined with
Alcohol
or
Opioid
s
Benzodiazepine Dependence
Benzodiazepine Dependence and tolerance may start within days to weeks of regular use
Benzodiazepine
GABA Receptor
Agonist
activity triggers receptor down regulation
Seizure
s may occur, especially if underlying
Seizure Disorder
See
Benzodiazepine Withdrawal
for taper schedules
Benzodiazepine
misuse and abuse is common
Hospital admissions for Benzodiazepine Abuse have increased three-fold since the early 2000s
Misuse in up to 17% of those in the U.S. taking
Benzodiazepine
s
Obtained from family or friends in 70% of misuse cases
Alprazolam
(
Xanax
) is among the most addictive
Benzodiazepine
s
Responsible for 10% of drug-misuse related visits to the Emergency Department
Rapid onset is associated with euphoria, short
Half-Life
is associated with rebound symptoms
Risk Factors
Other
Substance Use Disorder
Opioid Use Disorder
(70%)
Alcohol Use Disorder
(27%)
Tobacco Abuse
(OR 1.8)
Other associated factors
Young adults (esp. age 18 to 25 years)
Chronic
Sleep Disorders
Chronic illness
Diagnosis
DSM5 Criteria for
Sedative
, Hypnotic or
Anxiolytic
Use Disorder
Background
Sedative
, Hypnotic or
Anxiolytic
Use Disorder is a subset of
Substance Use Disorder
See
Substance Use Disorder
Sedative
, hypnotic or
Anxiolytic
use leads to significant
Impairment
or distress
"
Sedative
, hypnotic or
Anxiolytic
" are abbreviated as
Sedative
s in the criteria below
Criteria: At Least 2 of the following over the last 12 months
Sedative
s taken in larger amounts or over longer period than initially intended
Persistent desire or unsuccessful attempts to control or cut-down
Sedative
use
Considerable time spent to obtain, use or recover from
Sedative
use
Craving or strong desire to use
Sedative
s
Recurrent
Sedative
use results in failure to fulfill major obligations at work, school or home
Continued
Sedative
use despite social or interpersonal problems caused or exacerbated by
Sedative
s
Important social, occupational or recreational activities reduced or eliminated due to
Sedative
use
Recurrent
Sedative
use in physically hazardous settings
Continued
Sedative
use despite being aware of a physical or psychological complication of its use
Additional Criteria (if
Sedative
s NOT taken under medical supervision)
Tolerance
Need to markedly increase
Sedative
amounts to achieve
Intoxication
or desired effect
Markedly decreased effect with continued use of same amount of
Sedative
Withdrawal
Classic
Sedative
withdrawal symptoms (see
Benzodiazepine Withdrawal
)
Sedative
s or other related substances (e.g.
Alcohol
) are used to relieve withdrawal symptoms
Severity
Mild: 2 to 3 criteria present
Moderate: 4 to 5 criteria present
Severe: >=6 criteria present
References
(2022) DSM 5, APA, p. 620-22
Management
Mental health referral
Chemical Dependency
programs
Taper off
Benzodiazepine
s
See
Benzodiazepine Taper Schedule
Do NOT abruptly stop
Benzodiazepine
s
Refer to
Benzodiazepine
detox program in unreliable patients
Other adjunctive medications for
Benzodiazepine Withdrawal
symptoms
Valproate
Tricyclic Antidepressant
s
Beandrup (2018) Cochrane Database Syst Rev (3): CD011481 [PubMed]
Prevention
Avoid prescribing
Benzodiazepine
s if possible (maximize alternatives)
Limit
Benzodiazepine
prescriptions to lowest effective dose and frequency for the shortest course (<1 month)
References
Robertson (2022) Am Fam Physician 108(3): 260-6 [PubMed]
Type your search phrase here